____________________________________________________ Medical Marijuana and Other Cannabinoids MDRI05MM — 5 CE CREDIT HOURS R elease D ate : 12/01/23 E xpiration D ate : 11/30/26
Medical Marijuana and Other Cannabinoids In addition to receiving AMA PRA Category 1 Credit TM , physicians participating in Maintenance of Certification will receive the following points appropriate to their certifying board: 5 ABIM MOC Points, 5 ABS MOC Points, 5 ABPath CC Points.
Faculty Mark Rose, BS, MA, LP , is a licensed psychologist in the State of Minnesota with a private consulting practice and a medical research analyst with a biomedical communications firm. Earlier healthcare technology assessment work led to medical device and pharmaceutical sector experience in new product development involving cancer ablative devices and pain therapeutics. Along with substantial experience in addic- tion research, Mr. Rose has contributed to the authorship of numerous papers on CNS, oncology, and other medical disorders. He is the lead author of papers published in peer- reviewed addiction, psychiatry, and pain medicine journals and has written books on prescription opioids and alcoholism published by the Hazelden Foundation. He also serves as an Expert Advisor and Expert Witness to law firms that represent disability claimants or criminal defendants on cases related to chronic pain, psychiatric/substance use disorders, and acute pharmacologic/toxicologic effects. Mr. Rose is on the Board of Directors of the Minneapolis-based International Institute of Anti-Aging Medicine and is a member of several professional organizations. Faculty Disclosure Contributing faculty, Mark Rose, BS, MA, LP, has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
HOW TO RECEIVE CREDIT
• Read the enclosed course. • Complete the final examination questions at the end. A score of 70% is required. • Return your customer information/answer sheet, evaluation, and payment to InforMed by mail or complete online at BOOK.CME.EDU.
Audience This course is designed for physicians, nurses, physician assis- tants, pharmacists, social workers, therapists, and counselors in the primary care setting involved in the care of patients who use or who are candidates for the therapeutic use of marijuana or other cannabinoids. Course Objective The purpose of this course is to provide healthcare profession- als with unbiased and evidence-based information regarding the use of marijuana and other cannabinoids for the treatment
of medical condition. Learning Objectives
Upon completion of this course, you should be able to: 1. Recall the history of therapeutic cannabis use.
2. Outline the function of the endocannabinoid system. 3. Analyze the pharmacology of exogenous cannabinoids in clinical or experimental use. 4. Discuss potential side effects and areas of safety con- cern when medicinal cannabis and other cannabinoids are used. 5. Describe the potential therapeutic benefit and appro- priate indications for the medical use of marijuana and other cannabinoids. 6. Identify primary indications, side effects, chronic effects, and contraindications to therapeutic cannabi- noid use.
Division Planners John M. Leonard, MD
Randall L. Allen, PharmD Margaret Donohue, PhD Alice Yick Flanagan, PhD, MSW Margo A. Halm, RN, PhD, ACNS-BC Senior Director of Development and Academic Affairs Sarah Campbell Division Planner/Director Disclosure The division planners and director have disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
Mention of commercial products does not indicate endorsement.
63
MDRI2026
Powered by FlippingBook